Arctium lappa Linn.
1. Taxonomic, Nomenclature & Therapeutic Summary Table
| Botanical Attribute | Pharmacognostic & Therapeutic Specification |
|---|---|
| Family | Compositae; Asteraceae. |
| Habitat | Native to northern Europe; now found in western Himalayas, Kashmir and Simla. |
| English | Common or Great Burdock. |
| Folk | Phaggarmuul (Kashmir). |
| Action | Hypoglycaemic (plant extract caused reduction of blood sugar with an increase in carbohydrate tolerance). Roots—inhibitory of tumour growth, cardiac stimulant, diuretic, spasmolytic. Leaves and seeds—anticutaneous (used in psoriasis, seborrhoic eczema). |
| Key Application | As dermatological agent. (The British Herbal Pharmacopoeia.) |
| Taxonomic Cohort | Genus Arctium (1 documented species); Family Compositae (91 documented species). |
2. Classical Nomenclature, Taxonomy & Biogeographical Context
Arctium lappa (taxonomically cited with authority Linn.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Compositae; Asteraceae (primary family classification: Compositae), placing it within a well-defined chemotaxonomic group of medicinal flora. Within botanical taxonomy, this taxon is cataloged directly under its primary accepted binomial without secondary botanical synonyms. Biogeographically, its documented habitat and ecological distribution span: Native to northern Europe; now found in western Himalayas, Kashmir and Simla.
Across classical and vernacular Indian systems of medicine, Arctium lappa is recognized under distinct polyglot nomenclature: in English botanical and trade usage as Common or Great Burdock; in regional Indian folk and vernacular ethnobotany as Phaggarmuul (Kashmir). Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.
3. Therapeutic Actions, Phytochemistry & Pharmacological Profile
In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Arctium lappa are: Hypoglycaemic (plant extract caused reduction of blood sugar with an increase in carbohydrate tolerance). Roots—inhibitory of tumour growth, cardiac stimulant, diuretic, spasmolytic. Leaves and seeds—anticutaneous (used in psoriasis, seborrhoic eczema). These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias. Furthermore, international and national regulatory monographs highlight its validated key clinical application: As dermatological agent. (The British Herbal Pharmacopoeia.).
Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Arctium lappa establish the following evidence base: Important constituents of Burdock roots are fatty acids, organic acids, phenolic acids, lignans, sesquiterpenes, tannin, inulin and mucilage. Extracts of the fruit are reported to have hypoglycaemic activity in rats. Arctigenin (lignan) is a weak inhibitor of experimental tumour growth. The antimicrobial properties are due to polyacetylenes (of the root). The root exhibits antibiotic activity against Staphylococcus, and is used for fungal and bacterial infections. A flavonoid, arctiin, shows smooth muscle relaxant properties.

Botanical Reference 1: Arctium lappa — Botanical specimen

Botanical Reference 2: Arctium lappa — Botanical specimen

Botanical Reference 3: Arctium lappa — Wikimedia Commons reference
4. Comparative Genus & Family Pharmacognosy
Within Indian medicinal flora, Arctium lappa stands as a distinct representative of the genus Arctium. Its therapeutic profile underscores the role of selectively utilized medicinal genera alongside larger polytypic genera.
At the family level, Compositae encompasses 91 documented medicinal species (5.02% of the 1,814-species flora). Other representative medicinal members of Compositae include: Acanthospermum hispidum (Trikantaka), Achillea millefolium (Milfoil), Ainsliaea aptera (Karui Buuti), Amberboa divaricata (Brahmadandi), Anacyclus pyrethrum (Aakaarakarabha). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

Figure 1: Quantitative documentation profile across all 91 medicinal species of family Compositae.
5. Pharmacopoeial Standards, Posology & Reference Framework
In clinical and traditional dispensing, preparation and administration of Arctium lappa follow the plant-part modalities specified under its therapeutic action (Hypoglycaemic (plant extract caused reduction of blood sugar with an increase in carbohydrate tolerance). Roots—inhibitory of tumour growth, cardiac stimulant, diuretic, spasmolytic. Leaves and seeds—anticutaneous (used in psoriasis, seborrhoic eczema)), guided by the standard posological principles of The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and CCRAS formularies. Classical and modern pharmacognostic synchronization for Arctium lappa integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.